Breaking News, Promotions & Moves

Alcami Announces CEO Transition

Bill Humphries resigns; Patrick Walsh will serve as Interim CEO.

By: Kristin Brooks

Managing Editor, Contract Pharma

Patrick Walsh, Interim CEO.

Alcami Corp., a contract development and manufacturing organization, announced the resignation of Bill Humphries. Alcami’s Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO to ensure operations run smoothly.

“On behalf of the Board, I’d like to express gratitude to Bill for his leadership over the last two years during a critical time of facilities expansion and a global supply chain realignment. He was a strong advocate for our clients and the organization benefited from his leadership. I am personally grateful for his contributions and wish him all the best in his new opportunity,” said Walsh.

Mr. Walsh served as CEO of Alcami on two previous occasions and has served as Chairman over the last four years. In addition to his duties at Alcami, he currently serves as Chairman of ANI Pharmaceuticals, Inc., Chairman of MedPharm, and is an Operating Partner at Ampersand Capital Partners.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters